A prospective study of tBregs subsets has revealed an increased frequency of CD19+CD24hiCD38hi phenotype but a decreased proportion of differentiated CD27+ cells within this subset in patients with MS, suggesting a potential shift between Bregs cell maturation and effector memory B cells during the progression of MS [41]. The gene discussed is CD19; the disease is myeloid sarcoma.